United Kingdom· GB-APID-45442311000001104
Ixazomib 3mg capsules
A ixazomib product containing ixazomib, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ixazomib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XG03 (ixazomib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Ixazomib · ATC L01XG03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ixazomib costs, country by country.
Normalised to the WHO defined daily dose (0.43 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ixazomib · price per daily dose (0.43 mg)
USD · FX 28 Sept 2026
- CH Switzerland$395.98
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ixazomib
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XG03
- ATC class
- Ixazomib
- Defined daily dose
- 0.43 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
226 interactions on record for ixazomib.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ixazomib · interactions on record
226 records
- 45 severe
- 181 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- RifampicinJ04AB02severe
- RifabutinJ04AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ixazomib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesNINLAROTakeda Pharmaceuticals America, Inc.
- SwitzerlandNinlaro 3.0 mg, HartkapselnTakeda Pharma AG
- CzechiaNINLAROTakeda Pharma A/S, Vallensbaek Strand
- SpainNINLARO 3 MG CAPSULAS DURASTakeda Pharma A/S
- FinlandNINLAROTakeda Pharma A/S
- FranceNINLARO 3 mg, géluleTAKEDA PHARMA (DANEMARK)
- BelgiumNinlaro 3 mgTakeda Pharma
- IrelandNINLARO 3 mg hard capsulesTakeda Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ninlaro
- Liechtenstein · Ninlaro
- Norway · Ninlaro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/010dc012-86e9-4872-9116-b64ac0aedc5b GET /v1/drugs/010dc012-86e9-4872-9116-b64ac0aedc5b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45442311000001104",
"desc": "Ixazomib 3mg capsules (Takeda UK Ltd)",
"form": "Oral capsule",
"vpid": "34023411000001104",
"source": "dmd",
"vtm_id": "781325001",
"strength": "3 mg",
"substance": "Ixazomib",
"ingredient": "Ixazomib citrate",
"supplier_code": "3811601000001107"
}See everything about ixazomib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.